L3Harris Technologies earnings beat by $0.30, revenue topped estimates

L3Harris Technologies (LHX) reported robust second-quarter results, with EPS of $2.78 beating analyst estimates of $2.48 and revenue of $5.4 billion exceeding the $5.32 billion consensus. The company also provided a fiscal year 2025 EPS guidance range of $10.40-$10.60, aligning with current analyst consensus. Despite seeing significantly more negative EPS revisions than positive ones recently, LHX stock has demonstrated strong performance, up 24.77% in the last three months, and maintains a "good performance" financial health rating.

Analysis

L3Harris Technologies (LHX) delivered a robust second-quarter performance, exceeding analyst expectations on both top and bottom lines. The company reported an EPS of $2.78, a significant $0.30 beat over the $2.48 consensus, while revenue came in at $5.4 billion against an estimated $5.32 billion. Forward-looking guidance for fiscal year 2025 projects an EPS range of $10.40-$10.60, which aligns squarely with the current analyst consensus of $10.50, suggesting a stable outlook that meets market expectations. This solid operational report contrasts sharply with recent analyst sentiment; over the past 90 days, the company saw 15 negative EPS revisions compared to only two positive ones, indicating that the strong results may have surpassed a lowered bar of expectations. The stock's recent performance has been strong, with a 24.77% gain in the last three months, a move now supported by these earnings and the company's "good performance" financial health score.

Key Decisions for Investors

• The strong earnings and revenue beat provides fundamental validation for the stock's recent 24.77% price appreciation, supporting a hold or buy thesis for investors confident in the company's operational execution.
• Given that FY2025 EPS guidance merely meets consensus rather than exceeding it, investors should be cautious about expecting continued near-term momentum at the same rapid pace without new catalysts.
• It is critical to monitor the disparity between the strong results and the preceding wave of 15 negative analyst revisions; a reversal of this trend with upcoming positive revisions would be a strong bullish signal, whereas a failure to secure upgrades could cap further upside.